Bumper Offer - Urjas oil Just @ Rs. 1
Relif Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Allergy, Urticaria Pigmentosa, Common Cold. Secondary and off-label uses of Relif Tablet have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Relif Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Relif Tablet can also lead to other problems, which have been listed below. Normally, these side effects of Relif Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Relif Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Relif Tablet related warnings talks about Relif Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Kidney Disease, Liver Disease, Drug Allergies must refrain from the use of Relif Tablet since this can cause severe adverse effects. The section on Relif Tablet contraindications lists all such conditions.
Additionally, Relif Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Relif Tablet is not safe while driving, and is is not addictive in nature.
Relif Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Relif Tablet is used -
Severe
Moderate
Mild
Is the use of Relif Tablet safe for pregnant women?
Relif may have some side effects during pregnancy. Pregnant women should discontinue the use of Relif, and talk to their doctor, if they notice any discomfort.
Is the use of Relif Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Relif. If you see any side effects, stop taking Relif immediately and talk to your doctor. Take Relif again, only after your doctor's advice.
What is the effect of Relif Tablet on the Kidneys?
Relif rarely affects the kidneys.
What is the effect of Relif Tablet on the Liver?
Using Relif does not have any harmful effects on the liver.
What is the effect of Relif Tablet on the Heart?
Relif is rarely harmful for the heart.
Relif Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Relif Tablet unless your doctor advises you to do so -
Is this Relif Tablet habit forming or addictive?
Relif Tablet does not cause addiction.
Interaction between Food and Relif Tablet
Taking Relif Tablet with food does not harm your health.
Interaction between Alcohol and Relif Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Relif Tablet with alcohol will be.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 166-167
April Hazard Vallerand, Cynthia A. Sanoski. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 316-317
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; ZYRTEC® (cetirizine hydrochloride) Tablets and Syrup For Oral Use
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 136-137
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1065-1066
